Related references
Note: Only part of the references are listed.Visually sensitive seizures: An updated review by the Epilepsy Foundation
Robert S. Fisher et al.
EPILEPSIA (2022)
Efficacy of levetiracetam in STXBP1 encephalopathy with different phenotypic and genetic spectra
Qiu-Hong Wang et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2022)
SANAD II: Dear Levetiracetam, the Honeymoon Is Over
Adriana Bermeo-Ovalle
EPILEPSY CURRENTS (2022)
Antiseizure Medication Concentrations During Pregnancy Results From the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) Study
Page B. Pennell et al.
JAMA NEUROLOGY (2022)
Epilepsy Genetics and Precision Medicine in Adults: A New Landscape for Developmental and Epileptic Encephalopathies
Alvaro Beltran-Corbellini et al.
FRONTIERS IN NEUROLOGY (2022)
Challenge to levetiracetam's de facto position as generic first-line antiseizure medication
Aidan Neligan et al.
PRACTICAL NEUROLOGY (2022)
Efficacy comparison of oxcarbazepine and levetiracetam monotherapy among patients with newly diagnosed focal epilepsy in China: A multicenter, open-label, randomized study
Haoyue Zhu et al.
CNS NEUROSCIENCE & THERAPEUTICS (2022)
International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions
Nicola Specchio et al.
EPILEPSIA (2022)
A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam
Ciaran Campbell et al.
EPILEPSIA (2022)
Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020
Maja Hochbaum et al.
EPILEPSY & BEHAVIOR (2022)
Levetiracetam for Seizure Prophylaxis in Neurocritical Care: A Systematic Review and Meta-analysis
Taolin Fang et al.
NEUROCRITICAL CARE (2022)
Concentrations of antiseizure medications in breast milk of lactating women with epilepsy: A systematic review with qualitative synthesis
Ramzi Shawahna et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2022)
2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association
Steven M. Greenberg et al.
STROKE (2022)
Synaptopathies in Developmental and Epileptic Encephalopathies: A Focus on Pre-synaptic Dysfunction
Giulia Spoto et al.
FRONTIERS IN NEUROLOGY (2022)
Levetiracetam Mechanisms of Action: From Molecules to Systems
Itzel Jatziri Contreras-Garcia et al.
PHARMACEUTICALS (2022)
Efficacy and safety of antiseizure medication in post-stroke epilepsy
Yaroslav Winter et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2022)
Efficacy, Tolerability, and Retention of Antiseizure Medications in PRRT2-Associated Infantile Epilepsy
Jan H. Doring et al.
NEUROLOGY-GENETICS (2022)
Antiseizure medication for brain metastasis-related epilepsy: Findings of optimal choice from a retrospective cohort
Angel Aledo-Serrano et al.
EPILEPSY RESEARCH (2021)
Differences in levetiracetam and perampanel treatment-related irritability in patients with epilepsy
Naoya Hasegawa et al.
EPILEPSY & BEHAVIOR (2021)
Alternatives to valproate in girls and women of childbearing potential with Idiopathic Generalized Epilepsies: state of the art and guidance for the clinician proposed by the Epilepsy and Gender Commission of the Italian League Against Epilepsy (LICE)
Barbara Mostacci et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2021)
Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity A Randomized Clinical Trial
Keith Vossel et al.
JAMA NEUROLOGY (2021)
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial
Anthony Marson et al.
LANCET (2021)
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial
Anthony Marson et al.
LANCET (2021)
Uncommon epileptic syndromes in children: a review
Josefina de la Jara et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2021)
Etiology-specific response to antiseizure medication in focal epilepsy
Jakob I. Doerrfuss et al.
EPILEPSIA (2021)
An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study
Arjune Sen et al.
TRIALS (2021)
Anti-seizure Medication Prescription in Adult Outpatients With Epilepsy in China, 2013-2018
Lingyan Yu et al.
FRONTIERS IN NEUROLOGY (2021)
Epilepsy in Down Syndrome: A Highly Prevalent Comorbidity
Miren Altuna et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Response to antiseizure medications in epileptic patients with malformation of cortical development
Wei Chen et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2021)
A multi-disciplinary clinic for SCN8A-related epilepsy
John M. Schreiber et al.
EPILEPSY RESEARCH (2020)
Levetiracetam efficacy in PCDH19 Girls Clustering Epilepsy
Lynette G. Sadleir et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2020)
Clinical and experimental insight into pathophysiology, comorbidity and therapy of absence seizures
Vincenzo Crunelli et al.
BRAIN (2020)
Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial
James M. Chamberlain et al.
LANCET (2020)
Rapidity of CNS Effect on Photoparoxysmal Response for Brivaracetam vs. Levetiracetam: A Randomized, Double-blind, Crossover Trial in Photosensitive Epilepsy Patients
Ronald C. Reed et al.
CNS DRUGS (2020)
Antiseizure medication withdrawal in seizure-free patients with PCDH19-related epilepsy: A multinational cohort survey
Angel Aledo-Serrano et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2020)
Pharmacologic treatment and SUDEP risk A nationwide, population-based, case-control study
Olafur Sveinsson et al.
NEUROLOGY (2020)
Cerebrovascular disease burden in late-onset non-lesional focal epilepsy
Laura Abraira et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2019)
Prediction Tools for Psychiatric Adverse Effects After Levetiracetam Prescription
Colin B. Josephson et al.
JAMA NEUROLOGY (2019)
Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial
Stuart R. Dalziel et al.
LANCET (2019)
Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial
Mark D. Lyttle et al.
LANCET (2019)
Behavioral problems in children of mothers with epilepsy prenatally exposed to valproate, carbamazepine, lamotrigine, or levetiracetam monotherapy
Yfke Huber-Mollema et al.
EPILEPSIA (2019)
Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events
Michele Romoli et al.
JOURNAL OF NEUROLOGY (2019)
Effect of brivaracetam on the anger levels of epilepsy patients. A prospective open-labelled controlled study
Manuel Toledo et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2019)
Seizure management and prescription patterns of anticonvulsants in Dravet syndrome: A multicenter cohort study from Germany and review of literature
Susanne Schubert-Bast et al.
EPILEPSY & BEHAVIOR (2019)
Levetiracetam and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and epilepsy: a reasonable combination
Tim J. von Oertzen et al.
EUROPEAN HEART JOURNAL (2019)
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
Jaideep Kapur et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Clinical Use and Efficacy of Levetiracetam for Absence Epilepsies
Danielle Nolan et al.
JOURNAL OF CHILD NEUROLOGY (2019)
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Prophylactic Anticonvulsants in the Treatment of Adults with Metastatic Brain Tumors
Clark C. Chen et al.
NEUROSURGERY (2019)
Trends in antiepileptic drug treatment and effectiveness in clinical practice in England from 2003 to 2016: a retrospective cohort study using electronic medical records
Graham Powell et al.
BMJ OPEN (2019)
Use of Emergency Medication in Adult Patients with Epilepsy: A Multicentre Cohort Study from Germany
Jeannette Kadel et al.
CNS DRUGS (2018)
Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus
Adam Strzelczyk et al.
EPILEPSIA (2018)
Clinical and electrographic features of sunflower syndrome
Fiona M. Baumer et al.
EPILEPSY RESEARCH (2018)
Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry
Torbjorn Tomson et al.
LANCET NEUROLOGY (2018)
Genetic (idiopathic) epilepsy with photosensitive seizures includes features of both focal and generalized seizures
Jiao Xue et al.
SCIENTIFIC REPORTS (2018)
Levetiracetam-Induced Seizure Aggravation in Patients With Focal Cortical Dysplasia
Emilija Cvetkovska et al.
CLINICAL NEUROPHARMACOLOGY (2018)
Genetic (idiopathic) generalized epilepsy with occipital semiology
Pablo Gomez-Porro et al.
EPILEPTIC DISORDERS (2018)
Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition
Nancy Carney et al.
NEUROSURGERY (2017)
Resistance to valproic acid as predictor of treatment resistance in genetic generalized epilepsies
Joanna Gesche et al.
EPILEPSIA (2017)
Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy
Baibing Chen et al.
EPILEPSY & BEHAVIOR (2017)
Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study
Vincenzo Belcastro et al.
JOURNAL OF NEUROLOGY (2017)
Myoclonic epilepsy in Down syndrome and Alzheimer disease
J. S. Aller-Alvarez et al.
NEUROLOGIA (2017)
Initial Treatment for Nonsyndromic Early-Life Epilepsy: An Unexpected Consensus
Renee A. Shellhaas et al.
PEDIATRIC NEUROLOGY (2017)
Newer Antiepileptic Drugs in Status Epilepticus: Prescription Trends and Outcomes in Comparison with Traditional Agents
Isabelle Beuchat et al.
CNS DRUGS (2017)
Incidence and Impact of Subclinical Epileptiform Activity in Alzheimer's Disease
Keith A. Vossel et al.
ANNALS OF NEUROLOGY (2016)
Dramatic effect of levetiracetam in early-onset epileptic encephalopathy due to STXBP1 mutation
Robertino Dilena et al.
BRAIN & DEVELOPMENT (2016)
Network abnormalities and interneuron dysfunction in Alzheimer disease
Jorge J. Palop et al.
NATURE REVIEWS NEUROSCIENCE (2016)
Paradoxical exacerbation of myoclonic-astatic seizures by levetiracetam in myoclonic astatic epilepsy
Yamane Makke et al.
BMC PEDIATRICS (2015)
Epileptic encephalopathies: Optimizing seizure control and developmental outcome
Lara Jehi et al.
EPILEPSIA (2015)
A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy
Konrad J. Werhahn et al.
EPILEPSIA (2015)
Antiepileptic drug treatment of rolandic epilepsy and Panayiotopoulos syndrome: clinical practice survey and clinical trial feasibility
Louise C. Mellish et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2015)
Levetiracetam as alternative treatment in Jeavons syndrome
D. Parissis et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Genetic variation in dopaminergic activity is associated with the risk for psychiatric side effects of levetiracetam
Christoph Helmstaedter et al.
EPILEPSIA (2013)
Synaptic vesicle protein 2A: basic facts and role in synaptic function
Julieta Griselda Mendoza-Torreblanca et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2013)
KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy
Eugen Trinka et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Neurobehavioral effects of levetiracetam in brain tumor related epilepsy
Abigail Bernett et al.
FRONTIERS IN NEUROLOGY (2013)
Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders
Josef Finsterer et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model
Pascal E. Sanchez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
E. Sander Connolly et al.
STROKE (2012)
A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy
Cinzia Fattore et al.
EPILEPSIA (2011)
Synaptic vesicle protein 2A predicts response to levetiracetam in patients with glioma
M. de Groot et al.
NEUROLOGY (2011)
Steady-State Pharmacokinetics of Intravenous Levetiracetam in Neurocritical Care Patients
Dustin D. Spencer et al.
PHARMACOTHERAPY (2011)
Treatment and Management of Epilepsy in the Elderly Demented Patient
Sigmund Jenssen et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2010)
Benign epilepsy of childhood with centrotemporal spikes (BECTS): To treat or not to treat, that is the question
John R. Hughes
EPILEPSY & BEHAVIOR (2010)
Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy
Erwin A. van Vliet et al.
EPILEPSIA (2009)
Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers
Sjoukje T. Toering et al.
EPILEPSIA (2009)
A pilot trial of levetiracetam in eyelid myoclonia with absences (Jeavons syndrome)
Pasquale Striano et al.
EPILEPSIA (2008)
Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures
S. Noachtar et al.
NEUROLOGY (2008)
Adjunctive therapy of uncontrolled partial seizures with levetiracetam in Australian patients
Ernest R. Somerville et al.
EPILEPSY & BEHAVIOR (2007)
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy
M. J. Brodie et al.
NEUROLOGY (2007)
Levetiracetam in patients with generalised epilepsy and myoclonic seizures: An open label study
A Labate et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2006)
Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: Clinical observations
A Magaudda et al.
EPILEPSIA (2004)
Discontinuation of levetiracetam because of behavioral side effects - A case-control study
JR White et al.
NEUROLOGY (2003)
The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents
JM Rigo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: A multicenter, double-blind, responder-selected study evaluating monotherapy
E Ben-Menachem et al.
EPILEPSIA (2000)
Levetiracetam for partial seizures - Results of a double-blind, randomized clinical trial
JJ Cereghino et al.
NEUROLOGY (2000)